CYPRESS BIOSCIENCE

Cypress Bioscience is a medical service provider that facilitates individualized patient care. The service provides its patients with therapeutic and personalized medical services in a variety of needs such as isolated areas of pain, rheumatology, and physical medicine and rehabilitation. It also addresses challenging disorders such as fibromyalgia and rheumatoid arthritis. Furthermore, the organization engages in the development of drugs such as Savella, a milnacipran HCI for the treatment of fibromyalgia, as well as Prosorba, a medical device for rheumatoid arthritis. Cypress Bioscience was founded in 1981 and is based in San Diego, California.